UIMA:XETRA:XETRA-UBS ETF SICAV - MSCI Europe UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 82.41

Change

-0.35 (-0.42)%

Market Cap

USD 0.24B

Volume

46.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.13 (-0.26%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.06 (-0.33%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.08 (-0.30%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.08 (-0.27%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.09 (-0.37%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.41 (-0.90%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

-1.36 (-0.96%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.15 (-0.29%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.10 (-0.09%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.36 (-0.06%)

USD 80.38B

ETFs Containing UIMA:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.54% 37% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.54% 35% F 40% F
Trailing 12 Months  
Capital Gain 9.68% 42% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.68% 40% F 43% F
Trailing 5 Years  
Capital Gain 24.67% 50% F 55% F
Dividend Return 8.32% 48% F 37% F
Total Return 32.99% 54% F 56% F
Average Annual (5 Year Horizon)  
Capital Gain 8.97% 64% D 63% D
Dividend Return 10.04% 67% D+ 65% D
Total Return 1.07% 75% C 53% F
Risk Return Profile  
Volatility (Standard Deviation) 11.95% 53% F 62% D
Risk Adjusted Return 84.02% 80% B- 82% B
Market Capitalization 0.24B 49% F 44% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.